Herantis Pharma publishes newsletter for July-August
September 02, 2019 02:00 ET
|
Herantis Pharma Oyj
Herantis Pharma publishes newsletter for July-August Herantis Pharma Plc Press release 2 September 2019 at 9:00 am Herantis Pharma plc (“Herantis”) has published its newsletter for July-August...
Herantis Pharma Oyj:n puolivuosikatsaus 1.1.-30.6.2019 (tilintarkastamaton)
August 28, 2019 02:00 ET
|
Herantis Pharma Oyj
Herantis Pharma Oyj Yhtiötiedote 28.8.2019 klo 9:00 Herantis Pharma Oyj:n puolivuosikatsaus 1.1.-30.6.2019 (tilintarkastamaton) Satunnaistetut kliiniset tutkimukset Parkinsonin taudin ja...
Herantis Pharma Plc announces half year financial report January 1 - June 30, 2019 (unaudited)
August 28, 2019 02:00 ET
|
Herantis Pharma Oyj
Herantis Pharma Plc Company release August 28, 2019 at 9:00am Herantis Pharma Plc announces half year financial report January 1 - June 30, 2019 (unaudited) Randomized clinical studies in...
Herantis Pharma julkaisee touko-kesäkuun uutiskirjeen
July 01, 2019 02:00 ET
|
Herantis Pharma Oyj
Herantis Pharma julkaisee touko-kesäkuun uutiskirjeen Herantis Pharma Oyj Lehdistötiedote 1.7.2019 kello 9:00 Herantis Pharma Oyj (”Herantis”) on julkaissut touko-kesäkuun 2019 uutiskirjeensä,...
Herantis Pharma publishes newsletter for May-June
July 01, 2019 02:00 ET
|
Herantis Pharma Oyj
Herantis Pharma publishes newsletter for May-June Herantis Pharma Plc Press release 1 July 2019 at 9:00 am Herantis Pharma plc (“Herantis”) has published its newsletter for May-June 2019. The...
Neuronascent Announces FDA Clearance of IND Application for NNI-362 an Aging Therapy to Treat Alzheimer's Disease
May 07, 2019 05:00 ET
|
Neuronascent, Inc.
CLARKSVILLE, Md., May 07, 2019 (GLOBE NEWSWIRE) -- Neuronascent Inc., a privately-held neuron regeneration therapeutics company, today announced that the U.S. Food and Drug Administration (FDA) has...
Herantis Pharma julkaisee maalis-huhtikuun uutiskirjeen
May 06, 2019 02:00 ET
|
Herantis Pharma Oyj
Herantis Pharma julkaisee maalis-huhtikuun uutiskirjeen Herantis Pharma Oyj Lehdistötiedote 6.5.2019 kello 9:00 Herantis Pharma Oyj (”Herantis”) on julkaissut maalis-huhtikuun uutiskirjeensä, joka...
Herantis Pharma publishes newsletter for March-April
May 06, 2019 02:00 ET
|
Herantis Pharma Oyj
Herantis Pharma publishes newsletter for March-April Herantis Pharma Plc Press release 6 May 2019 at 9:00 am Herantis Pharma plc (“Herantis”) has published its newsletter for March-April. The...
Neurocrine Biosciences and Voyager Therapeutics Announce Phase I Results for VY-AADC in Patients with Parkinson’s Disease at the American Academy of Neurology Annual Meeting
May 05, 2019 09:05 ET
|
Voyager Therapeutics, Inc.
Results Confirm the Posterior Trajectory as an Additional Surgical Delivery Route for VY-AADC in Patients with Parkinson’s Disease Treatment with VY-AADC Improved Good ON Time (ON Time Without...
Anesthesia and Respiratory Devices Market To Reach USD 50.30 Billion By 2026 | Reports And Data
May 02, 2019 11:36 ET
|
Reports And Data
High prevalence of respiratory diseases, rise in population along with urbanization and increase in geriatric population is fueling the market demand. Market Size – USD 30.12 Billion in 2018,...